Future Fields

Expressing a herbicide tolerance trait is only half the battle, producing enough active protein is where pipelines stall. This latest technical article explores: 🟢 Protein supply gaps: Moving past plant extraction limits to secure regulatory test material. 🟢 Herbicide tolerance trait classes: Roles and tolerance pathways across major commercial enzymes. 🟢 Biomanufacturing hurdles: Highlighting solubility, assembly, and cofactor challenges in conventional hosts. ➡️ Explore the full article here 👇

Working on herbicide tolerance crop traits? Is your expression host delivering active, correctly folded, purified protein for downstream studies? 🌱 In Part 2 of our crop trait series, we examine major herbicide-tolerance (HT) enzyme, including EPSPS, HPPD, ALS/AHAS, PAT, AAD, and DMO, and address the gap between trait discovery and scalable protein supply. 👉 Read the full blog article here: https://lnkd.in/gHHMg83d/?utm_campaign=CropBlog2&utm_source=linkedin&utm_medium=paid&utm_id=1233493356&hsa_acc=512604048&hsa_cam=1233493356&hsa_grp=914816266&hsa_ad=1649299886&hsa_net=linkedin&hsa_ver=3

Working on herbicide tolerance crop traits? Is your expression host delivering active, correctly folded, purified protein for downstream studies? 🌱 In Part 2 of our crop trait series, we examine major herbicide-tolerance (HT) enzyme, including EPSPS, HPPD, ALS/AHAS, PAT, AAD, and DMO, and address the gap between trait discovery and scalable protein supply. 👉 Read the full blog article here: https://lnkd.in/gHHMg83d/?utm_campaign=CropBlog2&utm_source=linkedin&utm_medium=paid&utm_id=1233493356&hsa_acc=512604048&hsa_cam=1233493356&hsa_grp=914658386&hsa_ad=1649195406&hsa_net=linkedin&hsa_ver=3

High target complexity shouldn't mean high CHO costs or batch inconsistency. Discover how the EntoEngine® expression platform scales recombinant diagnostic antigens from feasibility to commercialization.

Conventional expression systems like CHO are pushing IVD production costs past sustainable limits. The EntoEngine platform offers high-quality recombinant proteins designed for commercial viability.

When complex proteins are needed, CHO expression can bleed your budget—causing projects to die before leaving feasibility. Explore a more scalable approach to diagnostic protein production.